Abstract 3441: A multivalent peptoid conjugate that inhibits therapy-resistant prostate cancer cell proliferation by modulating androgen receptor transcriptional activity
Justine Habault(New York University), Michael J. Garabedian(New York University)
Cited by 0
Related Papers
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
|Molecules|2019|281
Statins Promote the Regression of Atherosclerosis via Activation of the CCR7-Dependent Emigration Pathway in Macrophages
|PLoS ONE|2011|149
MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen
|PLoS Genetics|2021|28
A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer
|Molecular Cancer Therapeutics|2023|4